Laboratory guidance for SARS-CoV-2 testing

Laboratory guidance for SARS-CoV-2 testing We present the most up-to-date data on SARS-CoV-2 antibody timelines, including the longevity of antibodies, and the production and detection of neutralizing antibodies and provide practical guidance for clinical microbiology laboratories to both verify commercial serology assays and choose appropriate testing algorithms for their local populations. 2021-05-28 Public Health Agency of Canada open-ouvert@tbs-sct.gc.ca Health and SafetyCCDRCanada Communicable Disease ReportCOVID-19SARS-CoV-2coronaviruspandemicCanadaserological testingserology algorithms Laboratory guidance for SARS-CoV-2 testingHTML https://www.canada.ca/en/public-health/services/reports-publications/canada-communicable-disease-report-ccdr/monthly-issue/2021-47/issue-4-april-2021/laboratory-guidance-sars-cov-2-testing.html Laboratory guidance for SARS-CoV-2 testingHTML https://www.canada.ca/fr/sante-publique/services/rapports-publications/releve-maladies-transmissibles-canada-rmtc/numero-mensuel/2021-47/numero-4-avril-2021/guide-laboratoires-depistage-sras-cov-2.html

We present the most up-to-date data on SARS-CoV-2 antibody timelines, including the longevity of antibodies, and the production and detection of neutralizing antibodies and provide practical guidance for clinical microbiology laboratories to both verify commercial serology assays and choose appropriate testing algorithms for their local populations.

Data and Resources

Similar records